You are here

Novel Ultra-Flexible Hybrid Circuits for Intraocular Retinal Prostheses

Award Information
Agency: Department of Health and Human Services
Branch: National Institutes of Health
Contract: 2R42EY018794-02A1
Agency Tracking Number: R42EY018794
Amount: $1,384,448.00
Phase: Phase II
Program: STTR
Solicitation Topic Code: N
Solicitation Number: PA12-089
Timeline
Solicitation Year: 2013
Award Year: 2013
Award Start Date (Proposal Award Date): 2013-09-15
Award End Date (Contract End Date): 2017-07-31
Small Business Information
1009 CAPABILITY DR Suite 313
Raleigh, NC 27606-3601
United States
DUNS: 131630852
HUBZone Owned: No
Woman Owned: No
Socially and Economically Disadvantaged: No
Principal Investigator
 JAMES WEILAND
 (323) 442-6670
 jweiland@usc.edu
Business Contact
 JAMES WEILAND
Phone: (323) 442-6670
Email: jweiland@usc.edu
Research Institution
 UNIVERSITY OF SOUTHERN CALIFORNIA AND UCLA
 
UNIVERSITY OF CALIFORNIA LOS ANGELES Office of Contract and Grant Administration 11000 Kinross Avenue, Suite 211
LOS ANGELES, CA 90095-2000
United States

 () -
 Nonprofit College or University
Abstract

DESCRIPTION provided by applicant Retinal prosthetic devices currently under development are designed to bypass the non functioning portion of the visual pathway photoreceptor layer in individuals suffering from diseases including retinitis pigmentosa RP and age related macular degeneration AMD Current devices enable patients to only see object positions and read large letters and further technical advancements are required for improved vision and device safety These advancements include high resolution neural interfacing fully intraocular implantation tack free fixation of the electrodes in close proximit to the retina and ultra flexible reliable packaging This project will address each or these needs
This Small Business Technology Transfer Phase II project proposes development of Novel Ultra Flexible Hybrid Circuits for Intraocular Retinal Prostheses In these flexible retinal implants ultra thin silicon integrated circuits ICandapos s will be electrically connected to a flexibl electrode array and thin film antenna coil then fully encapsulated between multiple layers of polymers resulting in a monolithic implantable neural interface This implantable neural interface will consist of a microstimulator IC an electrode array a RF antenna and high density connections between components The polymer layers will serve not only as the device substrate but also as protection for the components from the corrosive effects of the biological fluids The device will be pre formed following the curvature of the eye and coupled with a superstructure so as to be under slight compression after implantation in the eye helping to hold it secure and stabilize the electrodes against the surface of the retina This will lead to a device with better visual acuity and to a safer retinal prosthesis without the use o a retinal tack
and the need of a cable penetrating the eye wall PUBLIC HEALTH RELEVANCE Advancements in microfabrication and materials have made possible the development of miniaturized flexible neural interfaces These medical devices are targeted at treating incurable neurological disorders Such diseases are widespread in the population as a whole and their impact on individual health is profound The progress made so far by us and many others in integrating miniaturized flexible circuits with microelectrode arrays and packaging solutions suitable for implant procedures demonstrates that our technology has the potential to lead to a successful commercialization of fully implantable wireless neural interfaces an essential requirement for clinical systems Medical devices like the retinal stimulator will make a real impact on public health by providing the neurosurgeon with entirely new sets of tools to deal with the many nervous system dysfunctions that afflict mankind

* Information listed above is at the time of submission. *

US Flag An Official Website of the United States Government